| Analyst / Firm | Company | Price | Rating | Price Target | Upside/Downside | Date |
|---|---|---|---|---|---|---|
Alx Oncology Holdings IncALXO | $2.06 | Strong Buy | $4.00 | +94.17% | 20 hours ago | |
Analyst RankingTop 7% #357 out of 5186 analysts Average Return+27.19% Win Rate60%26 out of 43 Risk vs RewardPoor Good Analyst ColorPiper Sandler's Allison Bratzel raised their price target on Alx Oncology Holdings (NASDAQ: ALXO) by 33.3% from $3 to $4 on 2026/02/05. The analyst maintained their Strong Buy rating on the stock. Bratzel said several updates from ALX Oncology Holdings catalyzed their price target move, including financing, the removal of gastric/GEJ revenue, and the inclusion of HER2+ and CD47-high 2L+ breast cancer. | ||||||
Tesla IncTSLA | $800.00 | Strong Buy | $850.00 | +6.25% | a day ago | |
Upgrade to Premium to View MoreStrong buys: Upgrade to Premium to view the rest of today's Strong Buy stocks from Wall Street's top analysts Already have access to Premium? Sign In | ||||||